Stage III deficient mismatch repair colon patients get greater benefit from earlier starting oxaliplatin-based chemotherapy regimen
Yixiang Zhan(Nankai University), Chunze Zhang(Tianjin People's Hospital), Qinghuai Zhang(Nankai University), Qiurong Han(Tianjin University of Traditional Chinese Medicine), Jing Ping Sun(Shanghai Jiao Tong University), Xia Hu(Yunnan Agricultural University), Hangyu Ping(Nankai University), Zhaoce Liu(Nankai University), Wanting Wang(Tianjin University of Traditional Chinese Medicine), Zili Zhang(Tianjin Medical University), Guihua Wang(Hengyang Academy of Agricultural Sciences), Suying Yan(Inner Mongolia Electric Power (China)), Kemin Ni(Nankai University), Xipeng Zhang(Central South University), Guoxun Li(Tianjin People's Hospital), Yaohong Liu(Nankai University), Xuanzhu Zhao(Jiangsu Province Hospital)
Cited by 2
Related Papers
M2 Macrophage-Derived Exosomes Promote Cell Migration and Invasion in Colon Cancer
|Cancer Research|2018|672
Phosphorylation of PDHA by AMPK Drives TCA Cycle to Promote Cancer Metastasis
|Molecular Cell|2020|266
IL-6 regulates autophagy and chemotherapy resistance by promoting BECN1 phosphorylation
|Nature Communications|2021|234
SETDB1-mediated methylation of Akt promotes its K63-linked ubiquitination and activation leading to tumorigenesis
|Nature Cell Biology|2019|204